Visit Our Blog
  • FDNA TELEHEALTH
  • Products
    • Face2Gene Labs
    • Face2Gene Clinic
  • About FDNA
  • News & Press
    • In The News
    • Press Releases
  • Contact
  • FDNA Insights

FDNA Insights

Categories
  • All
  • 2018
  • ACMG
  • Case Study
  • Events/Conferences
  • Face2Gene
  • Genomics
  • Pharma
  • Pharma
  • Phenotyping
  • Rare Diseases
  • Scientific Abstracts
  • Talks
  • Technology
  • Uncategorized
  • Videos
  • Webinar

FDNA Announces Genomics Collaborative® at a Global Innovation Summit

February 27, 2018

By Molly Shuttlesworth

Events/Conferences,Genomics,Phenotyping,Technology

English | Spanish

In a packed auditorium at Mexico City’s CENTRO University, FDNA’s Senior Director of Marketing, Jeff Daniels, announced the launch of the Genomics Collaborative. This initiative prompts clinicians, patients, advocates and researchers to join forces in an effort to accelerate breakthroughs in precision medicine. The Genomics Collaborative allows participants to access FDNA’s deep learning and next-generation phenotyping (NGP) technology to conduct research for the benefit of patients and health care practices.

Leaders and innovators from around the globe were gathered to learn about breakthroughs from the creative visionaries behind them at the Demand Solutions summit. Hosted by the renowned Inter-American Development Bank (BID), CNN and Entrepreneur Magazine, the event drew over 500 leaders and innovators and showcased thought leaders from startups, including Airbnb and several wearable technology and gaming companies.

During his presentation, Daniels highlighted FDNA’s use of artificial intelligence and facial analysis technologies to help patients around the world. Using the Yellow Brick Road Project’s “Morgan’s Story,” as a backdrop, Daniels shared how the struggle of two little girls and their families is faced by millions of people globally when searching for medical answers.

“With FDNA’s strength being in pattern recognition and artificial intelligence, we thought others might want to access our technology to support their research efforts as well. That’s why we are launching the Genomics Collaborative and announcing projects with hospitals, labs, countries who have genomics projects, patient advocacy groups, and dozens of other types of researchers, just like Morgan and Lillie’s group, the Yellow Brick Road Project. We intend to expand use of this technology to every disease, and to phenotypes beyond facial analysis—like voice, video, metabolites, analysis of clinical notes, and more.”

As part of the Genomics Collaborative, FDNA works with partners to design the future of health, together. By compiling and analyzing case data, such as patient photos, biometric data, clinical notes and disease history, scientists will be able to make breakthroughs in disease understanding. Unlocking the secrets to our genetic makeup is the key to a healthier world. By uncovering the genetic components of diseases, we can shorten the diagnostic odyssey, enable greater and earlier recognition of these conditions in the medical community, and lead the way to more personalized and effective therapy.

Daniels discussed FDNA’s accomplishments over the past few years in this space.

“This is Face2Gene,” said Daniels, as he shared a photograph of a doctor scanning a patient with her mobile phone. “Face2Gene is for healthcare providers, and it works on any computer, tablet or mobile device […] A doctor can take a photo of her patient, or list other patient features, and Face2Gene will produce a list of relevant diseases for the doctor to consider. For thousands of diseases, the technology can provide meaningful insights before symptoms even begin.”

“What’s more,” Daniels continued, “Face2Gene learns from diagnosed cases from its users, getting smarter every day. It’s called deep learning technology. Doctors from over 2,000 institutions in 130 countries worked to train this technology, including hundreds here in Mexico. It already recognizes features and genetic data for over 10,000 diseases.

“Instead of waiting years to get a diagnosis, like Morgan and Lillie did, like many of you or your loved ones have, doctors can tap into the collective experience of thousands of doctors globally to facilitate personalized medicine, getting us answers sooner.”

Get Involved. Join the Genomics Collaborative>>

More entries about Events/Conferences

Rare Diseases
 

A Rare Disease Day Reflection

Rare diseases affect roughly 30 million Americans, yet only 5 percent of the estimated 7,000 known rare diseases have cures Read more

Events/Conferences
 

What to Do and See at ASHG 2018

San Diego, CA – The FDNA team is excited to be back at the American Society of Human Genetics (ASHG) Read more

Events/Conferences
 

AI in Healthcare: Separating the Hype from the Hope

FDNA’s CEO Dekel Gelbman recently spoke to hundreds of leaders during the Stanford Big Data in Precision Health Summit. The Read more

Events/Conferences
 

FDNA and Face2Gene Featured at ESHG

  A flock of researchers from around the globe shared their findings in dysmorphology and molecular genetics at this year’s Read more

Events/Conferences
 

What to Do and See at ESHG

The European Society of Human Genetics (ESHG) 42nd Annual  Meeting 2018 MiCo – Milano Congressi · Milan, Italy · June Read more

Events/Conferences
 

The Road to Precision Medicine: Balancing Ethics and Efficiency

Artificial intelligence has increasingly become the basis for advancing precision medicine. Tomorrow, at the ReWork Deep Learning in Healthcare Summit Read more

Pharma
 

FDNA’s Keynote at ePharma: Using Next-Generation Phenotyping For Precision Medicine Across the Pharma Value Chain

NOTE: This post is based on a presentation made at the March 2018 ePharma conference in New York City.   Read more

Events/Conferences
 

What to Do and See at ACMG

The American College of Medical Genetics (ACMG) Annual Clinical Genetics Meeting 2018 Charlotte Convention Center · Charlotte, North Carolina · April 10-14, 2018 Read more

Events/Conferences
 

Greenwood Genetic’s Journey: Partnering to Improve Precision Medicine

In its 44 year history, Greenwood Genetic Center (GGC) has seen over 80,000 patient cases. That’s a lot of data. Read more

Events/Conferences
 

Happening at HIMMS: Precision Medicine Through Next-Generation Phenotyping—A Customer’s Journey

HIMSS Conference, Microsoft booth Thursday, March 7 3:40 PM PST Las Vegas, Nevada   As over 40,000 health IT professionals, Read more

Events/Conferences
 

FDNA Announces Genomics Collaborative® at a Global Innovation Summit

English | Spanish In a packed auditorium at Mexico City’s CENTRO University, FDNA’s Senior Director of Marketing, Jeff Daniels, announced Read more

Events/Conferences
 

Drug Delivery Partnership: Precision Medicine Drives Discovery, Development and Commercialization in Pharma

In an era of breakthrough advancements in healthcare, it is hard to believe that 90% of blockbuster medicines are only Read more

Events/Conferences
 

What to Do and See at ASHG

The American Society of Human Genetics 67th Annual Meeting (ASHG 2017) Orange County Convention Center · Orlando, Florida October 17-21, Read more

Events/Conferences
 

FDNA Presents Rare Disease Technologies at the 2017 Precision Medicine Summit at Boston Children’s Hospital

The Division of Genetics and Genomics Department of Medicine at Boston Children’s Hospital will present their exciting new Fall Precision Read more

Events/Conferences
 

Disorder: The Rare Disease Film Festival

Disorder: The Rare Disease Film Festival will be held October 2 & 3, 2017 in Boston, MA. This is a new event Read more

Events/Conferences
 

What to Do and See at ESHG 2017 in Copenhagen

Annual Clinical Genetics Meeting (ESHG 2017) Bella Center Copenhagen, Copenhagen, Denmark May 27-30, 2017 Copenhagen, Denmark – The time is yet again Read more

Rare Diseases
 

New Facial Analysis Discoveries for RASopathy Syndromes in the Year of Discovery

  In March, FDNA reached out to clinicians and patients globally as part of the Year of Discovery to collect Read more

Rare Diseases
 

FDNA Partners with Blueprint Genetics to Spotlight RASopathies During the Year of Discovery

FDNA’s Year of Discovery Initiative will spotlight a different genetic syndrome group each month as part of their mission to Read more

Events/Conferences
 

What to Do and See at ACMG 2017 in Phoenix, AZ

Annual Clinical Genetics Meeting (ACMG 2017) Phoenix Convention Center, Phoenix, Arizona March 21-25, 2017 Phoenix, Arizona – With ACMG just over Read more

Rare Diseases
 

FDNA Launches “Year of Discovery” for Rare Disease Day

FDNA Launches “Year of Discovery” for Rare Disease Day Boston-based health and tech start-up calls on patients and clinicians to share Read more

  • Contact Us
  • Privacy Policy
  • Terms of Use

Signup for News


* These fields are required.

© 2011-2021 FDNA INC. www.FDNA.com. All rights reserved.

Face2Gene is a search and reference tool provided for informational purposes and not intended to replace the clinician’s judgment or experience, nor should it be used to diagnose or treat medical conditions.